Albemarle (NYSE:ALB) PT Lowered to $170.00

Albemarle (NYSE:ALBGet Free Report) had its price target dropped by stock analysts at Evercore ISI from $190.00 to $170.00 in a report issued on Wednesday, Benzinga reports. The firm presently has an “outperform” rating on the specialty chemicals company’s stock. Evercore ISI’s price target would suggest a potential upside of 85.49% from the stock’s previous close.

ALB has been the topic of several other reports. Bank of America decreased their price target on shares of Albemarle from $135.00 to $126.00 and set a “buy” rating on the stock in a research note on Friday, August 2nd. Hsbc Global Res upgraded Albemarle to a “hold” rating in a report on Wednesday, July 17th. KeyCorp dropped their price target on Albemarle from $151.00 to $132.00 and set an “overweight” rating for the company in a research report on Monday, August 5th. Berenberg Bank downgraded Albemarle from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $160.00 to $83.00 in a research report on Wednesday, July 31st. Finally, Robert W. Baird cut Albemarle from an “outperform” rating to a “neutral” rating and dropped their target price for the company from $102.00 to $85.00 in a report on Monday, August 5th. Two equities research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $117.10.

Read Our Latest Report on Albemarle

Albemarle Price Performance

NYSE:ALB opened at $91.65 on Wednesday. The stock has a 50 day moving average of $90.48 and a two-hundred day moving average of $110.94. Albemarle has a 12 month low of $71.97 and a 12 month high of $203.62. The firm has a market cap of $10.77 billion, a P/E ratio of 33.33, a price-to-earnings-growth ratio of 3.48 and a beta of 1.57. The company has a current ratio of 2.67, a quick ratio of 1.91 and a debt-to-equity ratio of 0.38.

Albemarle (NYSE:ALBGet Free Report) last issued its quarterly earnings results on Wednesday, July 31st. The specialty chemicals company reported $0.04 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.53 by ($0.49). Albemarle had a positive return on equity of 6.38% and a negative net margin of 6.72%. The firm had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.34 billion. During the same period in the prior year, the firm earned $7.33 earnings per share. The business’s revenue was down 39.7% on a year-over-year basis. On average, analysts expect that Albemarle will post 1.67 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Albemarle

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. WFA Asset Management Corp purchased a new position in Albemarle in the 1st quarter valued at approximately $25,000. First Community Trust NA acquired a new position in shares of Albemarle during the second quarter worth about $25,000. CVA Family Office LLC lifted its stake in Albemarle by 610.0% in the second quarter. CVA Family Office LLC now owns 284 shares of the specialty chemicals company’s stock worth $27,000 after acquiring an additional 244 shares during the last quarter. Jones Financial Companies Lllp grew its holdings in Albemarle by 2,942.9% during the 4th quarter. Jones Financial Companies Lllp now owns 213 shares of the specialty chemicals company’s stock worth $31,000 after acquiring an additional 206 shares in the last quarter. Finally, First Financial Corp IN purchased a new stake in shares of Albemarle in the 1st quarter valued at approximately $32,000. 92.87% of the stock is currently owned by hedge funds and other institutional investors.

About Albemarle

(Get Free Report)

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

Featured Stories

Analyst Recommendations for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.